Beranger Lueza
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 3
- Lung Cancer Research Studies 2
- Colorectal Cancer Treatments and Studies 1
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Jean‐Pierre Pignon (11 shared papers)Jean-Yves Douillard (2 shared papers)Fortunato Ciardiello (1 shared paper)Dirk Arnold (1 shared paper)Eric Van Cutsem (1 shared paper)Volker Heinemann (1 shared paper)Josep M. Tabernero (1 shared paper)Alan Paul Venook (1 shared paper)
- Journals
- Annals of Oncology (4 papers)The European Journal of Health Economics (2 papers)Clinical Lung Cancer (1 paper)Systematic Reviews (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Beranger Lueza
16 papers receiving 978 citations
Beranger Lueza's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 616
- Hepatology 95
- Pathology and Forensic Medicine 155
- Cancer Research 111
- Pulmonary and Respiratory Medicine 214
Countries citing papers authored by Beranger Lueza
This map shows the geographic impact of Beranger Lueza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beranger Lueza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beranger Lueza more than expected).
Fields of papers citing papers by Beranger Lueza
This network shows the impact of papers produced by Beranger Lueza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beranger Lueza. The network helps show where Beranger Lueza may publish in the future.
Co-authors
The 25 scholars most cited alongside Beranger Lueza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials Hit paper breakdown → | 2017 | 653 |
| 2 | 2016 | 80 | |
| 3 | 2016 | 54 | |
| 4 | 2016 | 37 | |
| 5 | 2019 | 36 | |
| 6 | 2014 | 25 | |
| 7 | 2018 | 22 | |
| 8 | 2015 | 18 | |
| 9 | 2016 | 18 | |
| 10 | 2013 | 16 | |
| 11 | 2019 | 13 | |
| 12 | 2014 | 11 | |
| 13 | 2017 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2018 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2012 | 1 |
About Beranger Lueza
Beranger Lueza is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Economics and Econometrics and Cancer Research, having authored 17 papers that have together received 997 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Breast Cancer Treatment Studies (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Head and Neck Cancer Studies (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (616 citations), Hepatology (95 citations), Pathology and Forensic Medicine (155 citations), Cancer Research (111 citations) and Pulmonary and Respiratory Medicine (214 citations). Beranger Lueza has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Jean‐Pierre Pignon, Jean-Yves Douillard, Fortunato Ciardiello, Dirk Arnold, Eric Van Cutsem, Volker Heinemann, Josep M. Tabernero, Alan Paul Venook, Heinz‐Josef Lenz and Marc Peeters. Their work appears in journals such as Annals of Oncology, The European Journal of Health Economics, Clinical Lung Cancer, Systematic Reviews and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.